Physiomics Plc
PYC.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 38.3% | 74.5% | -50.6% | – |
| Cost of Goods Sold | £1 | £1 | £1 | £1 |
| Gross Profit | -£0 | -£0 | -£0 | -£0 |
| % Margin | -40.9% | -83.3% | -219.6% | -61.8% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -40.4% | -83.3% | -230.6% | -61.8% |
| Other Income/Exp. Net | -£0 | £0 | £0 | £0 |
| Pre-Tax Income | -£0 | -£0 | -£0 | -£0 |
| Tax Expense | £0 | -£0 | -£0 | -£0 |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -40.5% | -70.2% | -213.9% | -53.9% |
| EPS | -0.001 | -0.12 | -0.003 | -0.002 |
| % Growth | 99.4% | -3,900% | -100% | – |
| EPS Diluted | -0.001 | -0.12 | -0.003 | -0.002 |
| Weighted Avg Shares Out | 276 | 2 | 135 | 135 |
| Weighted Avg Shares Out Dil | 276 | 2 | 135 | 135 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -44.2% | -74.5% | -227.7% | -60.7% |